Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Long Term DebtTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CureVac N.V (CVAC) Long-Term Deferred Tax: 2020-2024

Historic Long-Term Deferred Tax for CureVac N.V (CVAC) over the last 5 years, with Dec 2024 value amounting to $5.4 million.

  • CureVac N.V's Long-Term Deferred Tax rose 728.43% to $4.7 million in Q2 2025 from the same period last year, while for Jun 2025 it was $4.7 million, marking a year-over-year increase of 728.43%. This contributed to the annual value of $5.4 million for FY2024, which is 34.97% down from last year.
  • According to the latest figures from FY2024, CureVac N.V's Long-Term Deferred Tax is $5.4 million, which was down 34.97% from $8.4 million recorded in FY2023.
  • Over the past 5 years, CureVac N.V's Long-Term Deferred Tax peaked at $8.4 million during FY2023, and registered a low of $530,569 during FY2020.
  • Its 3-year average for Long-Term Deferred Tax is $7.3 million, with a median of $8.1 million in 2022.
  • As far as peak fluctuations go, CureVac N.V's Long-Term Deferred Tax surged by 516.87% in 2021, and later plummeted by 34.97% in 2024.
  • CureVac N.V's Long-Term Deferred Tax (Yearly) stood at $530,569 in 2020, then spiked by 516.87% to $3.3 million in 2021, then soared by 148.41% to $8.1 million in 2022, then rose by 2.92% to $8.4 million in 2023, then plummeted by 34.97% to $5.4 million in 2024.